Friday, April 3, 2020

Gilead CEO says coronavirus hopeful remdesivir will be 'affordable,' but it could still rake in revenue

Monday, March 30, 2020
Will Gilead Sciences make a fortune out of remdesivir if the antiviral proves itself against the novel coronavirus?

No comments: